Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease". Simbrunner B, Costa D, Reiberger T. J Hepatol 2021;75:234-236.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Simbrunner B, Costa D, Reiberger T. Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease". J Hepatol 2021;75:234-236.
PMID: 33852949